CRH Medical Corporation opens center in Virginia

VANCOUVER, July 31 /PRNewswire-FirstCall/ - CRH Medical Corporation
(CRM:TSX-V) announced today that it has opened a Center for Colorectal Health
in Arlington Virginia. This Center is the Company's first center in the state
of Virginia, one of many new markets that CRH has targeted for expansion. The
opening of this location represents the 9th new Center opened in 2008 bringing
the Company's total number of Centers to 17.
According to the National Institute of Health, the prevalence rate of
hemorrhoids in the US is about 4.4% of the population. Approximately 50% of
the U.S. population will develop hemorrhoids by age 50. The Company plans to
significantly increase the number of Centers for Colorectal Health across the
U.S. to address this underserved market.

About CRH Medical Corporation:

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing
its proven treatment protocol and patented proprietary technology. CRH's
single use, disposable, hemorrhoid technology is safe and highly effective in
treating hemorrhoid grades I - IV. CRH Medical employs two commercialization
strategies: first, it operates Centers for Colorectal Health facilities in the
United States specializing in the treatment of hemorrhoids and fissures, and
colon cancer screening. In addition CRH distributes its hemorrhoid banding
technology, treatment protocols, operational and marketing expertise as a
complete, "turn key" package directly to its partner physicians. The Company's
goal is to establish the CRH hemorrhoid technology as the standard for
hemorrhoid treatment.

The information in this news release contains so-called "forward-looking"
statements. These include statements regarding CRH Medical expectations,
beliefs, intentions or strategies for the future, which may be indicated by
words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we
believe", "CRH Medical believes", "management believes" and similar language.
All forward-looking statements are based on CRH Medical current expectations
and are subject to risks and uncertainties and to assumptions made.

The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.

SOURCE CRH Medical Corporation

call Dean Linden, Investor Relations, CRH Medical Corporation, at (604)
633-1440, or ir@crhmedcorp.com. Additional information may also be found by
visiting the Company's website at www.crhmedcorp.com or the SEDAR website at
www.sedar.com